Muhammed Majeed,Kalyanam Nagabhushanam,Natarajan Sankaran,Priti Vaidyanathan,Sivakumar Arumugam,Suresh Kumar Karri
申请号：
US14536701
公开号：
US20160129054A1
申请日:
2014.11.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans comprising the oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing not less than 2 billion spores) along with standard treatment of care in a specific manner.
